# Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia

> **NCT01603394** · PHASE4 · TERMINATED · sponsor: **Pfizer** · enrollment: 9 (actual)

## Conditions studied

- Postherpetic Neuralgia

## Interventions

- **DRUG:** pregabalin

## Key facts

- **NCT ID:** NCT01603394
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01603394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01603394, "Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01603394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*